QUARTA, ERIDE
 Distribuzione geografica
Continente #
EU - Europa 700
NA - Nord America 423
AS - Asia 228
AF - Africa 7
SA - Sud America 5
OC - Oceania 4
Totale 1.367
Nazione #
US - Stati Uniti d'America 416
IT - Italia 258
IE - Irlanda 196
SG - Singapore 124
SE - Svezia 106
CN - Cina 80
DE - Germania 39
NL - Olanda 39
AT - Austria 20
FR - Francia 15
TR - Turchia 10
IN - India 9
FI - Finlandia 8
CA - Canada 7
AR - Argentina 5
CI - Costa d'Avorio 5
GB - Regno Unito 5
CZ - Repubblica Ceca 3
NZ - Nuova Zelanda 3
HK - Hong Kong 2
RO - Romania 2
RS - Serbia 2
RU - Federazione Russa 2
TH - Thailandia 2
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
NG - Nigeria 1
PT - Portogallo 1
UA - Ucraina 1
Totale 1.367
Città #
Dublin 192
Singapore 103
Chandler 97
Parma 69
Shanghai 46
Ashburn 44
Ann Arbor 38
Boardman 38
Groningen 33
Santa Clara 29
Milan 24
Vienna 18
Munich 17
Bologna 16
Reggio Emilia 13
Princeton 12
Rome 12
Seattle 11
Marseille 9
Ardea 8
Ferrara 8
Beijing 7
Helsinki 7
Des Moines 6
Falls Church 6
Stockholm 6
West Jordan 6
Wilmington 6
Abidjan 5
Dallas 5
Fremont 5
Guangzhou 5
Montegaldella 5
Segrate 5
Strasbourg 5
Assago 4
Brescia 4
Istanbul 4
Konyaalti 4
Los Angeles 4
Macomer 4
Ottawa 4
Padova 4
Auckland 3
Birmingham 3
Bremen 3
Brno 3
Buenos Aires 3
Chicago 3
Fairfield 3
Frankfurt am Main 3
Pune 3
Amsterdam 2
Bangkok 2
Belgrade 2
Bergamo 2
Brooklyn 2
Collecchio 2
Dearborn 2
Garden City 2
Grafing 2
Granarolo dell'Emilia e Viadagola 2
Hangzhou 2
Homburg 2
Hong Kong 2
Houston 2
Kocaeli 2
Leiden 2
Livorno 2
Lonato 2
Modena 2
Montelupone 2
New York 2
Nuremberg 2
Phoenix 2
Santa Teresa Di Riva 2
Syracuse 2
Turin 2
Vancouver 2
Villa Carlos Paz 2
Woodbridge 2
Adelaide 1
Bari 1
Baricella 1
Borås 1
Carpenedolo 1
Changsha 1
Chilly-mazarin 1
Delhi 1
Edinburgh 1
Hyderabad 1
Jiaxing 1
Kamampa 1
Miami 1
Neviano degli Arduini 1
New Delhi 1
Palermo 1
Pesaro 1
Piscataway 1
Pompiano 1
Totale 1.052
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 145
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 101
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 92
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 84
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 81
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 67
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 64
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 62
Nasal delivery as a strategy for the prevention and treatment of COVID-19 62
Respicell(TM): An innovative dissolution apparatus for inhaled products 58
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 56
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 52
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 48
Nuove composizioni antivirali e loro utilizzo in terapia e nel trattamento di infezioni virali 45
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 44
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 43
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 43
Calcium phosphate nanoparticle precipitation by a continuous flow process: A design of an experiment approach 40
Understanding the importance of capsules in dry powder inhalers 39
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles 36
Recent Patents on Nasal Vaccines Containing Nanoadjuvants 34
Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis 31
POWDER COMPOSITION BASED ON MICROPARTICLES EMBEDDING NANOPARTICLES FOR THE DELIVERY OF THERAPEUTIC/DIAGNOSTIC COMPOUNDS 31
Probing critical physical properties of lactose-polyethylene glycol microparticles in pulmonary delivery of chitosan nanoparticles 27
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 20
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract 14
Totale 1.419
Categoria #
all - tutte 6.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 1 5 2 2 2 0 6
2020/2021117 5 1 1 6 11 20 25 11 15 8 12 2
2021/2022112 3 3 8 5 20 5 12 8 9 1 7 31
2022/2023430 36 49 19 33 27 43 30 35 129 11 9 9
2023/2024438 11 18 8 20 26 59 112 31 24 31 45 53
2024/2025303 28 42 67 101 65 0 0 0 0 0 0 0
Totale 1.419